<p>Bioceres Crop Solutions（纳斯达克代码：BIOX - 获取免费报告）于周三发布了季度财报。该公司报告季度每股收益为（$0.12），低于市场共识预期的（$0.04），差距为（$0.08），据 Zacks 报道。Bioceres Crop Solutions 的股本回报率为负 14.72%，净利润率为负 15.27%。</p>
<h2>Bioceres Crop Solutions 价格表现</h2>
<ul>
<li>3 只低于$20 的超值股票，具有重大增长潜力</li>
</ul>
<p>周三午盘交易中，BIOX 股价下跌$0.06，达到$1.87。该公司股票交易量为 1,185,196 股，低于其平均交易量 1,248,524 股。该公司的债务与股本比率为 0.22，流动比率为 1.02，速动比率为 0.74。Bioceres Crop Solutions 的 1 年最低价为$1.20，1 年最高价为$7.44。该股票的市值为$118.24 百万，市盈率为-2.31，贝塔系数为 0.42。该公司的 50 日移动平均价格为$1.79，200 日移动平均价格为$3.27。</p>
<h2>机构投资者对 Bioceres Crop Solutions 的看法</h2>
<p>几家对冲基金最近调整了对该公司的持股。美国银行在第四季度将其在 Bioceres Crop Solutions 的股份增加了 186.8%。美国银行目前拥有 5,735 股该公司的股票，价值$35,000，此前在该期间又购买了 3,735 股。琼斯金融公司在第一季度将其在 Bioceres Crop Solutions 的持股增加了 3,535.8%。琼斯金融公司目前拥有 5,490 股该公司的股票，价值$25,000，此前在上个季度又收购了 5,339 股。简街集团在第二季度购买了 Bioceres Crop Solutions 的新头寸，价值$202,000。最后，PDT Partners 在第二季度将其在 Bioceres Crop Solutions 的持股增加了 58.9%。PDT Partners 目前拥有 28,180 股该公司的股票，价值$126,000，此前在上个季度又购买了 10,449 股。17.68% 的股票由机构投资者和对冲基金持有。</p>
<h2>分析师设定新目标价</h2>
<p>多家股票研究分析师对该股发布了报告。Lake Street Capital 将 Bioceres Crop Solutions 的目标价从$8.00 下调至$5.00，并在 9 月 10 日的报告中给予该股 “买入” 评级。Oppenheimer 在 10 月 22 日的研究报告中将 Bioceres Crop Solutions 的评级从 “跑赢大盘” 下调至 “市场表现”。Canaccord Genuity Group 在 9 月 10 日的报告中重申了 “持有” 评级，并将 Bioceres Crop Solutions 的目标价设定为$2.50（之前为$6.50）。Brookline Capital Management 在 8 月 21 日的研究报告中将 Bioceres Crop Solutions 的评级从 “强力买入” 下调至 “持有”。最后，Wall Street Zen 在 9 月 13 日的研究报告中将 Bioceres Crop Solutions 的评级从 “持有” 下调至 “卖出”。一位分析师给予该股 “买入” 评级，三位分析师给予 “持有” 评级，一位分析师给予 “卖出” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “持有”，平均目标价为$4.17。</p>
<p><strong>查看我们对 Bioceres Crop Solutions 的最新分析</strong></p>
<h2>Bioceres Crop Solutions 公司简介</h2>
<p>（获取免费报告）</p>
<p>Bioceres Crop Solutions Corp.及其子公司提供作物生产力解决方案。它通过种子与综合产品、作物保护和作物营养三个部门运营。种子与综合产品部门提供种子特性、种质和种子处理包，以促进更健康和更高产的作物。</p>
<h2>另请参阅</h2>
<ul>
<li>五只我们更看好的股票，胜过 Bioceres Crop Solutions</li>
<li>股息捕捉策略：你需要知道的事项</li>
<li>稀土股票：并非真正的停火</li>
<li>卖空 - 利弊分析</li>
<li>划分利润：感恩节餐桌上的 3 只食品股票</li>
<li>什么是内幕交易？你可以从内幕交易中学到什么</li>
<li>C3.ai 的重置：为什么新领导层可能会引发转机</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QklPWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QklPWA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Bioceres Crop Solutions 吗？</h2>
<p>在你考虑 Bioceres Crop Solutions 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Bioceres Crop Solutions 并不在名单上。</p>
<p>虽然 Bioceres Crop Solutions 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

BIOX

<p>Bioceres Crop Solutions (NASDAQ:BIOX) 报告的季度每股收益为（$0.12），比市场共识预期的（$0.04）低 $0.08。该公司的净利润率为负 15.27%，股本回报率为负 14.72%。股票下跌 $0.06，报 $1.87。分析师已调整了他们的评级和目标价格，一些分析师下调了该股票的评级。机构投资者已调整其持股，持有该股票的比例为 17.68%</p>

<p>Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.08), Zacks reports. Bioceres Crop Solutions had a negative return on equity of 14.72% and a negative net margin of 15.27%.</p>
<div class="lb-trans"><p>Bioceres Crop Solutions（纳斯达克代码：BIOX - 获取免费报告）于周三发布了季度财报。该公司报告季度每股收益为（$0.12），低于市场共识预期的（$0.04），差距为（$0.08），据 Zacks 报道。Bioceres Crop Solutions 的股本回报率为负 14.72%，净利润率为负 15.27%。</p>
</div><h2>Bioceres Crop Solutions Price Performance</h2>
<div class="lb-trans"><h2>Bioceres Crop Solutions 价格表现</h2>
</div><ul>
<li>3 Bargain Stocks Under $20 With Major Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只低于$20 的超值股票，具有重大增长潜力</li>
</ul>
</div><p>BIOX traded down $0.06 during midday trading on Wednesday, reaching $1.87. 1,185,196 shares of the company's stock were exchanged, compared to its average volume of 1,248,524. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.02 and a quick ratio of 0.74. Bioceres Crop Solutions has a 1-year low of $1.20 and a 1-year high of $7.44. The stock has a market capitalization of $118.24 million, a PE ratio of -2.31 and a beta of 0.42. The business's 50-day moving average price is $1.79 and its 200 day moving average price is $3.27.</p>
<div class="lb-trans"><p>周三午盘交易中，BIOX 股价下跌$0.06，达到$1.87。该公司股票交易量为 1,185,196 股，低于其平均交易量 1,248,524 股。该公司的债务与股本比率为 0.22，流动比率为 1.02，速动比率为 0.74。Bioceres Crop Solutions 的 1 年最低价为$1.20，1 年最高价为$7.44。该股票的市值为$118.24 百万，市盈率为-2.31，贝塔系数为 0.42。该公司的 50 日移动平均价格为$1.79，200 日移动平均价格为$3.27。</p>
</div><h2>Institutional Investors Weigh In On Bioceres Crop Solutions</h2>
<div class="lb-trans"><h2>机构投资者对 Bioceres Crop Solutions 的看法</h2>
</div><p>Several hedge funds have recently modified their holdings of the company. Bank of America Corp DE lifted its stake in shares of Bioceres Crop Solutions by 186.8% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after buying an additional 3,735 shares during the period. Jones Financial Companies Lllp raised its holdings in Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock valued at $25,000 after acquiring an additional 5,339 shares during the last quarter. Jane Street Group LLC purchased a new position in shares of Bioceres Crop Solutions during the 2nd quarter worth $202,000. Finally, PDT Partners LLC boosted its holdings in shares of Bioceres Crop Solutions by 58.9% during the second quarter. PDT Partners LLC now owns 28,180 shares of the company's stock worth $126,000 after purchasing an additional 10,449 shares during the last quarter. 17.68% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>几家对冲基金最近调整了对该公司的持股。美国银行在第四季度将其在 Bioceres Crop Solutions 的股份增加了 186.8%。美国银行目前拥有 5,735 股该公司的股票，价值$35,000，此前在该期间又购买了 3,735 股。琼斯金融公司在第一季度将其在 Bioceres Crop Solutions 的持股增加了 3,535.8%。琼斯金融公司目前拥有 5,490 股该公司的股票，价值$25,000，此前在上个季度又收购了 5,339 股。简街集团在第二季度购买了 Bioceres Crop Solutions 的新头寸，价值$202,000。最后，PDT Partners 在第二季度将其在 Bioceres Crop Solutions 的持股增加了 58.9%。PDT Partners 目前拥有 28,180 股该公司的股票，价值$126,000，此前在上个季度又购买了 10,449 股。17.68% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>A number of equities research analysts have issued reports on the stock. Lake Street Capital reduced their target price on shares of Bioceres Crop Solutions from $8.00 to $5.00 and set a &#34;buy&#34; rating on the stock in a report on Wednesday, September 10th. Oppenheimer downgraded Bioceres Crop Solutions from an &#34;outperform&#34; rating to a &#34;market perform&#34; rating in a research note on Wednesday, October 22nd. Canaccord Genuity Group reaffirmed a &#34;hold&#34; rating and issued a $2.50 price objective (down previously from $6.50) on shares of Bioceres Crop Solutions in a report on Wednesday, September 10th. Brookline Capital Management downgraded Bioceres Crop Solutions from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Thursday, August 21st. Finally, Wall Street Zen downgraded Bioceres Crop Solutions from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research note on Saturday, September 13th. One analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of &#34;Hold&#34; and an average target price of $4.17.</p>
<div class="lb-trans"><p>多家股票研究分析师对该股发布了报告。Lake Street Capital 将 Bioceres Crop Solutions 的目标价从$8.00 下调至$5.00，并在 9 月 10 日的报告中给予该股 “买入” 评级。Oppenheimer 在 10 月 22 日的研究报告中将 Bioceres Crop Solutions 的评级从 “跑赢大盘” 下调至 “市场表现”。Canaccord Genuity Group 在 9 月 10 日的报告中重申了 “持有” 评级，并将 Bioceres Crop Solutions 的目标价设定为$2.50（之前为$6.50）。Brookline Capital Management 在 8 月 21 日的研究报告中将 Bioceres Crop Solutions 的评级从 “强力买入” 下调至 “持有”。最后，Wall Street Zen 在 9 月 13 日的研究报告中将 Bioceres Crop Solutions 的评级从 “持有” 下调至 “卖出”。一位分析师给予该股 “买入” 评级，三位分析师给予 “持有” 评级，一位分析师给予 “卖出” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “持有”，平均目标价为$4.17。</p>
</div><p><strong>View Our Latest Analysis on Bioceres Crop Solutions</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Bioceres Crop Solutions 的最新分析</strong></p>
</div><h2>Bioceres Crop Solutions Company Profile</h2>
<div class="lb-trans"><h2>Bioceres Crop Solutions 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.</p>
<div class="lb-trans"><p>Bioceres Crop Solutions Corp.及其子公司提供作物生产力解决方案。它通过种子与综合产品、作物保护和作物营养三个部门运营。种子与综合产品部门提供种子特性、种质和种子处理包，以促进更健康和更高产的作物。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另请参阅</h2>
</div><ul>
<li>Five stocks we like better than Bioceres Crop Solutions</li>
<li>Dividend Capture Strategy: What You Need to Know</li>
<li>Rare Earth Stocks: The Truce That Isn't a Truce</li>
<li>Short Selling - The Pros and Cons</li>
<li>Carving Up Profits: 3 Food Stocks on the Thanksgiving Table</li>
<li>What is Insider Trading? What You Can Learn from Insider Trading</li>
<li>C3.ai's Reset: Why New Leadership Could Spark a Turnaround</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Bioceres Crop Solutions</li>
<li>股息捕捉策略：你需要知道的事项</li>
<li>稀土股票：并非真正的停火</li>
<li>卖空 - 利弊分析</li>
<li>划分利润：感恩节餐桌上的 3 只食品股票</li>
<li>什么是内幕交易？你可以从内幕交易中学到什么</li>
<li>C3.ai 的重置：为什么新领导层可能会引发转机</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QklPWA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=BIOX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Bioceres Crop Solutions Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Bioceres Crop Solutions 吗？</h2>
</div><p>Before you consider Bioceres Crop Solutions, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Bioceres Crop Solutions 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Bioceres Crop Solutions 并不在名单上。</p>
</div><p>While Bioceres Crop Solutions currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Bioceres Crop Solutions 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Bioceres Crop Solutions（NASDAQ:BIOX）公布了财报，每股收益比预期低 0.08 美元